About the Company
Novartis India Limited is a pharmaceutical company. The business operations of the Company include Pharmaceuticals, Generic, over the counter (OTC) and Animal Health. The Pharmaceuticals segment consists of a portfolio of prescription medicines, which are provided to patients through healthcare professionals. The Generics segment consists of retail generics products. The Generics segments unit primarily focuses on the therapeutic segments, such as Anti-TB, Anti-DUB (Gynaecology), Anti-histamines, Antibiotics, Anti-ulcerants, Anti-diabetes and Cardiovascular. The Animal Health segment has a presence primarily in the cattle and poultry market segments. The OT C segment is mainly in the vitamins, minerals and nutritional supplements (VMS) and cough, cold and allergy (CoCoA) market segments. During the fiscal year ended March 31, 2012, it introduced Enplus product in the Poultry segment, and Dexbov, Antifur, Vayuhara, Vetimam and Feedavit in the Cattle segment..The company also in the business activities of OTC, Generics, Animal Health, Pharmaceuticals.
{"success":1,"data":{"address":{"address1":"Inspire - BKC, 7th Floor,","address2":",","city":"Mumbai","state":"Maharashtra","pincode":"400051","telephone1":"22-50243000","telephone2":"","fax1":"22-50243010","fax2":"","email":"india.investors@novartis.com","web":"http:\/\/www.novartis.in"},"management":[{"name":"Christopher Snook","designation":"Chairperson"},{"name":"Shilpa Joshi","designation":"WholeTime Director & CFO"},{"name":"Falin Majmudar","designation":"Whole Time Director"},{"name":"Sandra Martyres","designation":"Independent Director"},{"name":"Sanker Parameswaran","designation":"Independent Director"}],"registrars":{"name":"MUFG Intime India Pvt. Ltd.","address1":"C 101, 247 Park,\nL.B.S. Marg, Vikhroli (West),","address2":"","address3":"","address4":"","telephone":"022-49186270, 49186200","fax":"022-49186060","email":"rnt.helpdesk@linkintime.co.in","internet":"http:\/\/www.linkintime.co.in","city":"Mumbai","state":"Maharashtra","pincode":"400083"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"No"},{"name":"Nifty 200","value":"No"}],"details":{"bseId":"500672","nseId":"NOVARTIND","series":"EQ","isinid":"INE234A01025"}}}
-
Registered Office
-
Registrars
-
Management
- Christopher Snook
Chairperson
- Shilpa Joshi
WholeTime Director & CFO
- Falin Majmudar
Whole Time Director
- Sandra Martyres
Independent Director
- Sanker Parameswaran
Independent Director
-
Included In
- BSE 100
No
- BSE 200
No
- SENSEX
No
- CNX MIDCAP 200
No
- NIFTY 50
No
- BSE 500
No
- Nifty 200
No
-
Details
- BSE:
500672
- NSE:
NOVARTIND
- Series
EQ
- ISIN
INE234A01025
